2024年12月19日，歐盟食品安全局（EFSA）發布消息，歐盟食品安全局（EFSA）發布關于植物乳桿菌（Lactiplantibacillus plantarum）NCIMB 40027作為所有動物飼料添加劑的授權更新申請的評估。
經過評估，專家小組得出結論，該添加劑在授權使用條件下對所有動物物種、消費者和環境都是安全的。在授權更新的情況下，無需評估添加劑的功效。部分原文報道如下：
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of the authorisation of Lactiplantibacillus plantarum NCIMB 40027 as a technological additive (functional group: silage additives) for use in fresh material for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing terms of the authorisation. The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the additive remains safe for all animal species, consumers, and the environment. Regarding user safety, the FEEDAP Panel reiterates its previous conclusion that the additive is not irritant to skin or eyes. However, it should be considered as a skin and respiratory sensitiser, and any exposure through the skin and respiratory tract is considered a risk. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
經過評估，專家小組得出結論，該添加劑在授權使用條件下對所有動物物種、消費者和環境都是安全的。在授權更新的情況下，無需評估添加劑的功效。部分原文報道如下：
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of the authorisation of Lactiplantibacillus plantarum NCIMB 40027 as a technological additive (functional group: silage additives) for use in fresh material for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing terms of the authorisation. The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the additive remains safe for all animal species, consumers, and the environment. Regarding user safety, the FEEDAP Panel reiterates its previous conclusion that the additive is not irritant to skin or eyes. However, it should be considered as a skin and respiratory sensitiser, and any exposure through the skin and respiratory tract is considered a risk. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
